Anticoagulation in COVID-19
Bassam Atallah, Saad I. Mallah, Wael Almahmeed
Abstract
As hospitals worldwide continue to admit an influx of coronavirus disease 2019 (COVID-19) patients, the puzzling pathogenesis behind the witnessed mortality rates is progressively being pieced together. Aside from the established respiratory involvement, the cardiac system has recently been implicated, albeit with controversial mechanisms. New data from cohort studies and autopsies suggest a potential role for coagulopathy in COVID-19. Although the exact mechanism may likewise remain controversial, several clinical implications are now imperative for discussion.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyMedicineCoronavirus InfectionsInternal medicineOutbreakInfectious disease (medical specialty)DiseaseVenous Thromboembolism Diagnosis and ManagementCOVID-19 Clinical Research StudiesAtrial Fibrillation Management and Outcomes